» Articles » PMID: 27111077

Association Between Serum Relaxin and Subsequent Shoulder Instability

Overview
Journal Orthopedics
Specialty Orthopedics
Date 2016 Apr 26
PMID 27111077
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Ligamentous laxity correlates with shoulder instability. Relaxin is a hormone that has been linked to laxity in the knee and has been shown to be a risk factor for anterior cruciate ligament (ACL) injury. This study prospectively evaluated the association between relaxin and acute shoulder instability. A prospective cohort study of 1050 young athletes was performed between 2006 and 2010. The authors conducted a nested case-control analysis within this cohort to evaluate the association between preinjury serum relaxin concentration and the likelihood of subsequent shoulder instability. The study compared 53 patients who had shoulder instability and 53 control subjects who were matched for sex, age, height, and weight. The serum relaxin concentration in preinjury baseline samples was tested with enzyme-linked immunosorbent assay analysis in duplicate. Independent t tests were performed to identify differences in mean serum relaxin concentration between patients with shoulder instability and uninjured control subjects. Logistic regression was used to evaluate whether preinjury baseline serum relaxin concentration was associated with the subsequent likelihood of shoulder instability. Of the 53 patients with instability, 13 (25%) had a detectable serum relaxin concentration compared with 9 (17%) of uninjured control subjects (P=.34). Mean serum relaxin concentration in the injury group was 3.69±1.78 pg/mL and 2.20±0.97 pg/mL in uninjured control subjects (P=.02). Increased serum relaxin concentration was associated with the subsequent likelihood of acute shoulder instability. Subjects were 2.18 times (odds ratio, 2.18; 95% confidence interval, 1.01-4.76) more likely to have acute shoulder instability during the follow-up period for every 1-pg/mL increase in serum relaxin concentration at baseline. The findings suggest that serum relaxin concentration is associated with a risk of subsequent shoulder instability in young athletes. Further research on the role of relaxin in shoulder instability is warranted. [Orthopedics. 2016; 39(4):e724-e728.].

Citing Articles

Relaxin as a treatment for musculoskeletal fibrosis: What we know and future directions.

Nourmahnad A, Shariyate M, Khak M, Grinstaff M, Nazarian A, Rodriguez E Biochem Pharmacol. 2024; 225:116273.

PMID: 38729446 PMC: 11179965. DOI: 10.1016/j.bcp.2024.116273.


Multidirectional instability in female athletes.

Bishop M, Patel H, Erickson B, Dodson C Ann Jt. 2024; 7:10.

PMID: 38529164 PMC: 10929405. DOI: 10.21037/aoj-20-33.


Significance of plasma relaxin-2 levels in patients with primary hypertension and type 2 diabetes mellitus.

Pankova O, Korzh O Wien Med Wochenschr. 2024; 174(7-8):161-172.

PMID: 38451351 DOI: 10.1007/s10354-024-01035-x.


The role of relaxin in anterior cruciate ligament injuries: a systematic review.

Berger G, Rockov Z, Byrne C, Trentacosta N, Stone M Eur J Orthop Surg Traumatol. 2023; 33(8):3319-3326.

PMID: 37300589 DOI: 10.1007/s00590-023-03618-7.


Sports-Related Shoulder Injuries Among Female Athletes.

Wright C, Patel J, Hettrich C Curr Rev Musculoskelet Med. 2022; 15(6):637-644.

PMID: 36469281 PMC: 9789246. DOI: 10.1007/s12178-022-09802-2.